Ticker: NIKA

Nika Pharmaceuticals, Inc. (PINK: NIKA) Quick read: Nika remains a pre-revenue pharmaceutical issuer that is funding operations through related‑party advances, completing mergers and licensing deals, and investing in prospective manufacturing capacity - but faces material going‑concern risk, rela...

Nika Pharmaceuticals, Inc. (PINK: NIKA) recently released its Q1 2025 financial results. Below are key highlights from the income statement and the company’s operational status. Positive Aspects: Reduced Operating Expenses: Total operating expenses decreased significantly to $12,945 in Q1 2025 f...